Since the rebirth of pharmacogenomics (PGx) in the 1990s and 2000s, with new discoveries
of genetic variation underlying adverse drug response and new analytical technologies such …

Objective Poor knowledge and confidence in pharmacogenomics are key barriers to
implementation. Education of future healthcare professionals is required to enhance …

Background Pharmacists' contribution to pharmacogenomics (PGx) implementation in
clinical practice is vital, but a great proportion of them are not aware of PGx and its …

Pharmacists play a pivotal role in pharmacogenomic (PGx) implementation in clinical
practice, and their university education is considered a strong driver in holding favorable …

The field of pharmacogenomics is at the forefront of a healthcare revolution, promising to
usher in a new era of precision medicine. The intricate interplay between genes and …

Ensuring that patients have an adequate understanding of pharmacogenomic (PGx) test
results is a critical component of implementing precision medicine into clinical care …

Introduction Genome sequencing has utility, however, it may reveal secondary findings.
While Western bioethicists have been occupied with managing secondary findings …

Clinical trial and individual patient treatment outcomes have produced accumulating
evidence that effective primaquine (PQ) treatment of Plasmodium vivax and P. ovale liver …

Background: Precision medicine beckons new horizons for therapy geared to one's
genetics, lifestyle, and environmental determinants. Molecular, pathology, and clinical …

Background Clopidogrel is a widely prescribed prodrug that requires activation via specific
pharmacogenes to exert its anti-platelet function. Genetic variations in the genes encoding …